In fact there is a great deal of uncertainty regarding future drug prices, and it is one of many factors rattling biotech investment.
And we're talking pharma inflating prices to increase dividend/buybacks/exec compensation rather than investing in R&D. Different ball of wax from biotech startups looking for investment
And we're talking pharma inflating prices to increase dividend/buybacks/exec compensation rather than investing in R&D. Different ball of wax from biotech startups looking for investment